🚨 Special Access Program (SAP) — Access to Drugs Not Approved in Canada

The Special Access Program (SAP) is a Health Canada initiative that allows Canadian health care professionals to request access to drugs that are not authorized for sale in Canada — including pharmaceutical, biologic, and radiopharmaceutical products — for patients with serious or life‑threatening conditions when conventional therapies have failed, are unsuitable, or are unavailable.

👩‍⚕️ Who Can Apply

Only licensed health care professionals (typically physicians) who are authorized to prescribe in their province or territory can submit a SAP request on behalf of a patient. They must:

  • Be entitled under local laws to treat patients with a prescription drug;
  • Practice in that province or territory;
  • Have prescribing privileges in that region.

The practitioner also must ensure the patient is informed of possible risks, benefits, and the development status of the requested drug.

📝 How SAP Works

To request access to a drug under the SAP:

  1. ✔ Complete the SAP request form (patient‑specific or future‑use form).
  2. ✔ Fax the completed form to the SAP office (no cover sheet needed).
  3. ✔ Wait for a decision — urgent cases may be processed within hours, while other requests depend on the information provided and availability.

Decisions can result in authorization (letter sent to manufacturer and practitioner), denial, cancellation (if the drug becomes marketed), or return for incomplete information.

⚠️ When SAP Is Used

SAP access is intended *only* for:

  • 📍 Patients with severe or life‑threatening conditions;
  • 🧪 Conventional treatments have failed, are unsuitable, or are unavailable; and
  • 💊 No marketed alternative exists in Canada.

It is not a fast‑track drug approval pathway or a substitute for clinical trials or standard regulatory approval.

📍 Types of Access Requests

  • Patient‑Specific Request — Access for a named patient in immediate need.
  • Future Use Request — Pre‑positioning or stockpiling for anticipated emergencies.

📦 Costs and Supply

There is no standard SAP fee. The drug manufacturer sets the cost, and in some cases it may be free. Costs, if charged, may be covered by insurers, hospitals, patients, or families.

Drugs authorized through SAP are typically supplied directly from the manufacturer to the prescribing practitioner’s office, hospitals, pharmacies, or other designated sites.

🧠 Practitioner & Patient Responsibilities

  • 📋 Practitioners must document credible evidence supporting the use of the drug for the patient;
  • 📊 Follow‑up reporting on patient outcomes, including serious adverse reactions, is mandatory;
  • 🗂️ Practitioners must keep accurate records in case SAP requests accounting information.

🕐 Processing & Timelines

SAP receives approximately 1,000 drug requests per month; urgent life‑threatening cases are prioritized and often resolved within hours. Other requests depend on completeness and evidence provided.

📌 Key Considerations

  • 📍 Authorization does *not* mean Health Canada endorses the drug’s safety or efficacy — decisions are based on practitioner judgment and submitted evidence;
  • 📍 The manufacturer may impose conditions such as quantity limits or usage restrictions;
  • 📍 SAP access is separate from clinical trial enrolment or standard drug approval pathways.

🔗 Related Resources